China Chip Self-Reliance (Domestic Growth Theme)
The U.S. government has tightened restrictions, blocking Nvidia from selling its specialized AI chips to China. This policy shift is expected to boost China's domestic semiconductor industry as the nation strives for technological self-sufficiency.
Your Basket's Financial Footprint
Interpretation of the basket's market capitalisation and investor takeaways.
- Large-cap dominance generally implies lower volatility and returns that more closely track broad market performance.
- Use as a core portfolio holding for stable sector exposure, not as a speculative growth position.
- Expect steady long-term value appreciation rather than short-term explosive gains; growth is likely gradual.
TSM: $1.23T
QCOM: $185.50B
ASML: $399.32B
- Other
About This Group of Stocks
Our Expert Thinking
US restrictions on AI chip sales to China are accelerating Beijing's push for technological self-sufficiency. This creates a powerful catalyst for growth across China's domestic semiconductor value chain, from chip design to manufacturing equipment. We've identified companies positioned to benefit from this strategic pivot towards independence.
What You Need to Know
This group spans the entire semiconductor ecosystem - foundries, packaging, testing, and equipment suppliers. These companies operate in a high-growth environment driven by geopolitical necessity rather than just market demand. The theme represents both tactical opportunity and long-term structural change in global tech supply chains.
Why These Stocks
Each company was handpicked by professional analysts for their strategic position in the semiconductor supply chain transformation. From Taiwan's leading foundries to specialised chip designers, these stocks represent key players that Chinese tech giants will increasingly rely on as they reduce dependence on US technology.
Why You'll Want to Watch These Stocks
Geopolitical Catalyst at Work
US chip restrictions aren't just policy - they're forcing an entire industry transformation. Chinese tech giants now have no choice but to accelerate their shift to domestic suppliers, creating unprecedented demand.
Strategic Necessity Meets Opportunity
This isn't optional growth - it's survival-driven expansion. When governments prioritise technological independence, the companies that can deliver solutions often see explosive demand and government backing.
Supply Chain Revolution Underway
We're witnessing a fundamental rewiring of global semiconductor supply chains. The companies positioned at the centre of this shift could benefit from years of sustained, policy-driven growth.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.